|
|
||||||||
1 Human Performance Laboratory, University of Nebraska, Kearney, Nebraska 68849; and 2 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75235-8857
The effects of castration and dihydrotestosterone (DHT) treatment on levels of skeletal muscle androgen receptor (AR) were examined in three groups of adult male rats: 1) intact normal rats, 2) rats castrated at 16 wk of age, and 3) rats castrated at 16 wk of age and given DHT for 1 wk starting at week 17. All animals were killed at 18 wk of age. Castration caused a decrease (P < 0.05) in the weights of the levator ani and bulbocavernosus muscles. The administration of DHT to the castrated rats increased (P < 0.05) the weights of the levator ani and bulbocavernosus muscles. Castration caused a significant downregulation of AR levels in the bulbocavernosus (P < 0.05) but had no significant effect on AR levels in the levator ani muscle. DHT administration to the castrated group upregulated AR levels in the bulbocavernosus and levator ani muscles. The plantaris muscle did not significantly (P > 0.05) change for any of the treatments. These findings suggest that the effects of castration and androgen replacement differentially affect skeletal muscle mass and AR levels.
steroids; muscle fiber; growth; myofiber; anabolic steroid
This article has been cited by other articles:
![]() |
A.-M. Axell, H. E. MacLean, D. R. Plant, L. J. Harcourt, J. A. Davis, M. Jimenez, D. J. Handelsman, G. S. Lynch, and J. D. Zajac Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E506 - E516. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, J. D Zajac, and H. E MacLean Androgen regulation of satellite cell function J. Endocrinol., July 1, 2005; 186(1): 21 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McClung, K. A. Mehl, R. W. Thompson, L. L. Lowe, and J. A. Carson Nandrolone decanoate modulates cell cycle regulation in functionally overloaded rat soleus muscle Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1543 - R1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sinha-Hikim, W. E. Taylor, N. F. Gonzalez-Cadavid, W. Zheng, and S. Bhasin Androgen Receptor in Human Skeletal Muscle and Cultured Muscle Satellite Cells: Up-Regulation by Androgen Treatment J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5245 - 5255. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lee, R. W. Thompson, J. M. McClung, and J. A. Carson Regulation of androgen receptor expression at the onset of functional overload in rat plantaris muscle Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1076 - R1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lee, J. McClung, G. A. Hand, and J. A. Carson Overload-induced androgen receptor expression in the aged rat hindlimb receiving nandrolone decanoate J Appl Physiol, March 1, 2003; 94(3): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Carson, W. J. Lee, J. McClung, and G. A. Hand Steroid receptor concentration in aged rat hindlimb muscle: effect of anabolic steroid administration J Appl Physiol, July 1, 2002; 93(1): 242 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Wolf, A. Hotchkiss, J. S. Ostby, G. A. LeBlanc, and L. E. Gray Jr. Effects of Prenatal Testosterone Propionate on the Sexual Development of Male and Female Rats: A Dose-Response Study Toxicol. Sci., January 1, 2002; 65(1): 71 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhasin, L. Woodhouse, R. Casaburi, A. B. Singh, D. Bhasin, N. Berman, X. Chen, K. E. Yarasheski, L. Magliano, C. Dzekov, et al. Testosterone dose-response relationships in healthy young men Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1172 - E1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King Endocrine Responses to Chronic Androstenedione Intake in 30- to 56-Year-Old Men J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4074 - 4080. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |